The Effect of Virtual Reality Experience on Infusion-related Pain
Launched by SEOUL NATIONAL UNIVERSITY · Jul 26, 2020
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality (VR) can help reduce pain during a medical procedure called lumbar epidural catheterization, which is often needed for people with chronic low back pain. The researchers want to see if using a VR experience can make this procedure more comfortable for patients. The trial is currently looking for participants who are adults over 20 years old and have been suffering from chronic low back pain for more than three months, specifically due to conditions like spinal stenosis or lumbar disc disease.
To join the study, individuals must be able to give their own consent and meet certain health criteria. Unfortunately, those with specific health issues, such as certain infections or conditions that affect hearing or vision, will not be able to participate. If you join the trial, you can expect to experience a VR program while undergoing the infusion, with the hope that it will help manage pain during the process. This study is a great opportunity for eligible participants looking for new ways to cope with their pain.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: If all of the following conditions are met
- • A person with chronic low back pain that lasts more than 3 months due to spinal stenosis or lumbar disc disease.
- • Adults over 20
- • Those who decided to participate out of his/her own free will and signed in written consent
- • Exclusion Criteria: If the patient meets one or more of the following criteria, He or She cannot participate this clinical trial.
- • In case of contraindication to general lumbar catheterization (e.g. coatulopathy, infection, etc)
- • Hearing and vision impairments
- • Affective disorder
- • History of epilepsy or seizure
- • If communication is not possible due to impaired cognitive ability
- • Those who have been deemed inappropriate by the researchers
About Seoul National University
Seoul National University (SNU), a prestigious institution located in South Korea, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient outcomes. Renowned for its commitment to innovation and excellence, SNU collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous studies across various fields of medicine. The university's robust infrastructure and emphasis on interdisciplinary collaboration enable the development of novel therapeutic strategies and the exploration of cutting-edge technologies, ultimately contributing to the global body of medical knowledge and enhancing healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Jee Youn Moon, PhD
Study Director
Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials